A medical education website, Univadis, has been set up in
India by MSD Pharmaceuticals Pvt Ltd, the Indian arm of US-based Merck &
MSD, in collaboration with the Lancet, one of the leading
global independent general medical journals, has launched this unique,
interactive online medical education portal exclusively for Indian healthcare
The website will provide access to a plenty of medical
resources and accredited education courses from reputed and independent
The website, Univadis, has been launched in more than 40
countries and is available in 17 languages.
It currently has more than 20 million registered users worldwide.
The online portal is available free of cost for healthcare
professionals and does not display any product advertising.
K G Ananthakrishnan, managing director, MSD India, said, "We
are proud to launch Univadis in India to aid comprehensive healthcare
management, thereby making available unbiased, reliable scientific medical
information across all parts of the country. Univadis portal provides high
quality online education enabling healthcare practitioners to expand their
knowledge and expertise and thereby offer better quality of care to their patients.
MSD is known to be a trusted partner for continuous medical education across
the globe and in India."
On strategic partnership with Univadis, Dr David
Collingridge, publishing director for The Lancet's speciality journals the
Lancet, said that it offers a unique opportunity to increase delivery of the
best science to Indian doctors in a free and easily accessible format, which
will help promote best clinical practice and health systems reform.